MedPath

EFFECT OF NAYANSUKHAVARTI ANJANA IN THE MANAGEMENT OF PROGRESSIVE PTERYGIUM:

Not Applicable
Conditions
Health Condition 1: H110- Pterygium of eye
Registration Number
CTRI/2021/12/038432
Lead Sponsor
SHRI AYURVED MAHAVIDYALAYA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1 PATIENTS HAVING LAKSHANAS OF PRASTARI ARMA LIKE MAMSVRIDDHI UPTO LIMBUS AND LESS THAN LIMBUS RAGA NETRASTRAVE TODA AVILDARSHAN 2 PATIENTS WILLING AND ABLE TO PARTICIPATE FOR 1 MONTH OF TREATMENT

Exclusion Criteria

1 PATIENTS HAVING ARMA INDICATED FOR SURGERY ENCROACHING ON CORNEA MORE THAN LIMBAL MARGIN 2 PATIENTS HAVING MAJOR AND COMPLICATED SYSTEMIC DISEASES LIKE DM HTN AND OTHER EYE DISEASES 3 PATIENTS OF CORNEAL ULCER ,MALIGNANT EYE CONDITION DACROCYSTITIS

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A COMPARATIVE CLINICAL STUDY TO EVALUATE EFFICACY OF NAYANSUKHAVARTI ANJANA AND CHANDRODAYAVARTI ANJANA IN PRASTARI ARMATimepoint: THE DRUG WILL BE GIVEN 30 DAYS THE PATIENT WILL ASSESSED BEFORE AND AFTER TREATMENT TOTAL DURATION OF STUDY WILL BE 18 MONTHS
Secondary Outcome Measures
NameTimeMethod
TO COMPARE THE LEVEL OF TODA RAGA NETRASTRAV AVILDARSHAN IN THE PATIENTS OF PRASTARI ARMA IN BOTH GROUPSTimepoint: 0TH 7TH 15TH 30TH DAY
© Copyright 2025. All Rights Reserved by MedPath